(Q50540355)

English

Angiotensin II plays a critical role in diabetic pulmonary fibrosis most likely via activation of NADPH oxidase-mediated nitrosative damage.

scientific article published on 12 April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

Angiotensin II plays a critical role in diabetic pulmonary fibrosis most likely via activation of NADPH oxidase-mediated nitrosative damage. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

pulmonary fibrosis

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

author name string

Junling Yang

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

Yi Tan

2

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

Fenglian Zhao

3

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

Zhongsen Ma

4

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

Yuehui Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

Shirong Zheng

6

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

Jerry Yu

8

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

Xia Yin

9

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

Yang Zheng

10

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

Xiaokun Li

11

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

Lining Miao

12

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

Lu Cai

13

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

publication date

12 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

American Journal of Physiology - Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

301

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

E132-44

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

Angiotensin II revisited: new roles in inflammation, immunology and aging

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Connective tissue growth factor (CCN2, CTGF) and organ fibrosis: lessons from transgenic animals

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

The pathobiology of diabetic complications: a unifying mechanism

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Mechanism of angiotensin II-induced superoxide production in cells reconstituted with angiotensin type 1 receptor and the components of NADPH oxidase

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Cerebrovascular nitrosative stress mediates neurovascular and endothelial dysfunction induced by angiotensin II.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Angiotensin II stimulates synthesis of endothelial nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Lung function changes related to diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

NAD(P)H oxidase activation: a potential target mechanism for diabetic vascular complications, progressive beta-cell dysfunction and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Supplementation with tetrahydrobiopterin prevents the cardiovascular effects of angiotensin II-induced oxidative and nitrosative stress

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Association of restrictive ventilatory dysfunction with insulin resistance and type 2 diabetes in koreans.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Systematic review of the association between lung function and Type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

The renin-angiotensin system mediates hyperoxia-induced collagen production in human lung fibroblasts

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Overexpression of metallothionein reduces diabetic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Pulmonary lesions in cats with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Experimental diabetes and the lung. I. Changes in growth, morphometry, and biochemistry

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Association between low pulmonary function and metabolic risk factors in Korean adults: the Korean National Health and Nutrition Survey

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Adenoviral vector demonstrates that angiotensin II-induced depression of the cardiac baroreflex is mediated by endothelial nitric oxide synthase in the nucleus tractus solitarii of the rat

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Capillary and aortic endothelia interact in situ with nonenzymatically glycated albumin and develop specific alterations in early experimental diabetes.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Diabetic Cardiomyopathy in OVE26 Mice Shows Mitochondrial ROS Production and Divergence Between In Vivo and In Vitro Contractility

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

New mechanisms of pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Influence of hyperglycemia to the severity of pulmonary fibrosis.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Pulmonary function in diabetes: a metaanalysis

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Lung function abnormalities in children with type I diabetes.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Angiotensin II type-1 receptor antagonist attenuates LPS-induced acute lung injury.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Lung function and risk of type 2 diabetes and fatal and nonfatal major coronary heart disease events: possible associations with inflammation

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Inflammatory mechanisms of diabetic complications

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Losartan attenuates bleomycin-induced pulmonary fibrosis in rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Peroxynitrite and the regulation of Na(+),K(+)-ATPase activity by angiotensin II in the rat proximal tubule

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Development of late-stage diabetic nephropathy in OVE26 diabetic mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00629.2010

21 January 2018

Identifiers

10.1152/AJPENDO.00629.2010

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/21487074

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50540355&oldid=1233792976"